These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 36285145)

  • 61. Tissue-engineered vascular grafts demonstrate evidence of growth and development when implanted in a juvenile animal model.
    Brennan MP; Dardik A; Hibino N; Roh JD; Nelson GN; Papademitris X; Shinoka T; Breuer CK
    Ann Surg; 2008 Sep; 248(3):370-7. PubMed ID: 18791357
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Development of the novel biotube inserting technique for acceleration of thick-walled autologous tissue-engineered vascular grafts fabrication.
    Ma N; Wang Z; Chen H; Sun Y; Hong H; Sun Q; Yin M; Liu J
    J Mater Sci Mater Med; 2011 Apr; 22(4):1037-43. PubMed ID: 21331604
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Tissue Engineered Vascular Graft Recipient Interleukin 10 Status Is Critical for Preventing Thrombosis.
    Mirhaidari GJM; Barker JC; Zbinden JC; Santantonio BM; Chang YC; Best CA; Reinhardt JW; Blum KM; Yi T; Breuer CK
    Adv Healthc Mater; 2020 Dec; 9(24):e2001094. PubMed ID: 33073543
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Functional growth in tissue-engineered living, vascular grafts: follow-up at 100 weeks in a large animal model.
    Hoerstrup SP; Cummings Mrcs I; Lachat M; Schoen FJ; Jenni R; Leschka S; Neuenschwander S; Schmidt D; Mol A; Günter C; Gössi M; Genoni M; Zund G
    Circulation; 2006 Jul; 114(1 Suppl):I159-66. PubMed ID: 16820566
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Zoledronate alters natural progression of tissue-engineered vascular grafts.
    Chang YC; Li J; Mirhaidari G; Zbinden J; Barker J; Blum K; Reinhardt J; Best C; Kelly J; Shoji T; Yi T; Breuer C
    FASEB J; 2021 Oct; 35(10):e21849. PubMed ID: 34473380
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Future Perspectives on the Role of Stem Cells and Extracellular Vesicles in Vascular Tissue Regeneration.
    Cunnane EM; Weinbaum JS; O'Brien FJ; Vorp DA
    Front Cardiovasc Med; 2018; 5():86. PubMed ID: 30018970
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Electrospinning of biomimetic scaffolds for tissue-engineered vascular grafts: threading the path.
    Woods I; Flanagan TC
    Expert Rev Cardiovasc Ther; 2014 Jul; 12(7):815-32. PubMed ID: 24903895
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Controlled and Synchronised Vascular Regeneration upon the Implantation of Iloprost- and Cationic Amphiphilic Drugs-Conjugated Tissue-Engineered Vascular Grafts into the Ovine Carotid Artery: A Proteomics-Empowered Study.
    Antonova L; Kutikhin A; Sevostianova V; Lobov A; Repkin E; Krivkina E; Velikanova E; Mironov A; Mukhamadiyarov R; Senokosova E; Khanova M; Shishkova D; Markova V; Barbarash L
    Polymers (Basel); 2022 Nov; 14(23):. PubMed ID: 36501545
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Dynamic culture conditions to generate silk-based tissue-engineered vascular grafts.
    Zhang X; Wang X; Keshav V; Wang X; Johanas JT; Leisk GG; Kaplan DL
    Biomaterials; 2009 Jul; 30(19):3213-23. PubMed ID: 19232717
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Electrochemical fabrication of a biomimetic elastin-containing bi-layered scaffold for vascular tissue engineering.
    Nguyen TU; Shojaee M; Bashur CA; Kishore V
    Biofabrication; 2018 Nov; 11(1):015007. PubMed ID: 30411718
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Novel application and serial evaluation of tissue-engineered portal vein grafts in a murine model.
    Maxfield MW; Stacy MR; Kurobe H; Tara S; Yi T; Cleary MA; Zhuang ZW; Rodriguez-Davalos MI; Emre SH; Iwakiri Y; Shinoka T; Breuer CK
    Regen Med; 2017 Dec; 12(8):929-938. PubMed ID: 29215317
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Arterial tissue regeneration for pediatric applications: inspiration from up-to-date tissue-engineered vascular bypass grafts.
    Cittadella G; de Mel A; Dee R; De Coppi P; Seifalian AM
    Artif Organs; 2013 May; 37(5):423-34. PubMed ID: 23551257
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clinical Application for Tissue Engineering Focused on Materials.
    Kitsuka T; Hama R; Ulziibayar A; Matsuzaki Y; Kelly J; Shinoka T
    Biomedicines; 2022 Jun; 10(6):. PubMed ID: 35740460
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Rational design of an improved tissue-engineered vascular graft: determining the optimal cell dose and incubation time.
    Lee YU; Mahler N; Best CA; Tara S; Sugiura T; Lee AY; Yi T; Hibino N; Shinoka T; Breuer C
    Regen Med; 2016 Mar; 11(2):159-67. PubMed ID: 26925512
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Biomechanical diversity despite mechanobiological stability in tissue engineered vascular grafts two years post-implantation.
    Khosravi R; Miller KS; Best CA; Shih YC; Lee YU; Yi T; Shinoka T; Breuer CK; Humphrey JD
    Tissue Eng Part A; 2015 May; 21(9-10):1529-38. PubMed ID: 25710791
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Novel Association of miR-451 with the Incidence of TEVG Stenosis in a Murine Model.
    Hibino N; Best CA; Engle A; Ghimbovschi S; Knoblach S; Nath DS; Ishibashi N; Jonas RA
    Tissue Eng Part A; 2016 Jan; 22(1-2):75-82. PubMed ID: 26573748
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Compositions Including Synthetic and Natural Blends for Integration and Structural Integrity: Engineered for Different Vascular Graft Applications.
    Shojaee M; Bashur CA
    Adv Healthc Mater; 2017 Jun; 6(12):. PubMed ID: 28371505
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparison of human bone marrow mononuclear cell isolation methods for creating tissue-engineered vascular grafts: novel filter system versus traditional density centrifugation method.
    Hibino N; Nalbandian A; Devine L; Martinez RS; McGillicuddy E; Yi T; Karandish S; Ortolano GA; Shin'oka T; Snyder E; Breuer CK
    Tissue Eng Part C Methods; 2011 Oct; 17(10):993-8. PubMed ID: 21609305
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Tissue engineering in the vasculature.
    Naito Y; Rocco K; Kurobe H; Maxfield M; Breuer C; Shinoka T
    Anat Rec (Hoboken); 2014 Jan; 297(1):83-97. PubMed ID: 24293111
    [TBL] [Abstract][Full Text] [Related]  

  • 80. TGF-β receptor 1 inhibition prevents stenosis of tissue-engineered vascular grafts by reducing host mononuclear phagocyte activation.
    Lee YU; de Dios Ruiz-Rosado J; Mahler N; Best CA; Tara S; Yi T; Shoji T; Sugiura T; Lee AY; Robledo-Avila F; Hibino N; Pober JS; Shinoka T; Partida-Sanchez S; Breuer CK
    FASEB J; 2016 Jul; 30(7):2627-36. PubMed ID: 27059717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.